arrow
N

Nicholas A. Vitanza

Seattle Children's Research Institute
H指数:33
被引数:4,102

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intracerebroventricular B7-H3-targeting chimeric antigen receptor T cells for non-pontine diffuse midline glioma and recurrent/refractory pediatric CNS tumors: A phase 1 trial

脑室内B7-H3靶向嵌合抗原受体T细胞治疗非脑桥弥漫性中线胶质瘤和复发/难治性儿童中枢神经系统肿瘤:一项1期临床试验

2026-07-250
PRE
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma

组合B7-H3 CAR T细胞与ONC206对弥漫性内生性脑桥胶质瘤的疗效研究

2026-03-011
PRE
A Cavernous Sinus Meningioma in a Child with Progressive Bilateral Visual Loss Ultimately Attributed to Unsuspected Optic Nerve Sheath Meningiomas

一名儿童患有海绵窦脑膜瘤,表现为进行性双侧视力丧失,最终归因于未预料的视神经鞘脑膜瘤

2026-01-010
OA
Engineered CXCR3-A expression enhances B7-H3-targeting CAR T cell migration and efficacy against diffuse intrinsic pontine glioma

工程化CXCR3-A表达增强B7-H3靶向CAR T细胞的迁移和对弥漫性内生性脑桥胶质瘤的疗效

2025-11-110
OAAI
Leveraging the immunomodulatory effects of dordaviprone (ONC201) to induce long-term survival response in diffuse midline glioma patients and models

利用dordaviprone(ONC201)的免疫调节作用,在弥漫性中线胶质瘤患者和模型中诱导长期生存反应

2025-11-010
OAAI
ENHANCING GENOME ANALYSIS WITH WHOLE PROTEOME PROFILING FOR IMPROVED THERAPEUTIC DECISION MAKING IN DIFFUSE MIDLINE GLIOMA

通过全蛋白质组分析增强基因组分析,以改善弥漫性中线胶质瘤的治疗决策制定

2025-11-010
OAAI
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04

开创性四靶点CAR T细胞疗法在儿童中枢神经系统肿瘤中的应用——来自第一项人体I期临床试验BRAINCHILD-04的分析

2025-11-010
OAAI
Tumor inflammation-associated neurotoxicity in children with diffuse intrinsic pontine glioma receiving B7-H3-targeting CAR T cells on BrainChild-03

儿童弥漫性内生性脑桥胶质瘤患者在接受B7-H3靶向CAR T细胞治疗(BrainChild-03)时出现的肿瘤炎症相关神经毒性

2025-09-011
PRE
Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trial

Gust J,Cole BL,Ronsley R,Wilson AL,Seidel K,Wendler J,等. 局部区域灌注EGFR806-CAR T细胞治疗复发或难治性儿童中枢神经系统肿瘤:已完成brainChild02期1临床试验的结果. Neuro Oncol. (2025). doi: 10.1093/neuonc/noaf064

2025-06-016
PRE
PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS - ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04
2024-11-110
PRE
An international study presenting a federated learning AI platform for pediatric brain tumors
2024-09-020
OAAI
INTRAVENTRICULAR B7-H3 CAR T CELLS FOR DIFFUSE INTRINSIC PONTINE GLIOMA: SAFETY AND EFFICACY REPORT FROM THE COMPLETED PHASE 1 TRIAL BRAINCHILD-03

脑室内B7-H3 CAR T细胞治疗弥漫性内在性脑桥胶质瘤: 已完成的1期试验BRAINCHILD-03的安全性和有效性报告

2024-06-181
OAAI
DRD2 ANTAGONISM RESCUES IMMUNE-TUMOR SURVEILLANCE, WARMING THE TUMOR IMMUNE MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA MODELS
2024-06-180
OAAI